US Stock MarketDetailed Quotes

CAMP Camp4 Therapeutics

Watchlist
  • 8.120
  • -1.490-15.50%
Close Nov 15 16:00 ET
158.38MMarket Cap-3185P/E (TTM)

Camp4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.56%-44.16M
-38.54M
Net income from continuing operations
-11.54%-49.29M
---44.19M
Depreciation and amortization
91.12%1.68M
--878K
Other non cash items
7.69%1.82M
--1.69M
Change In working capital
-174.47%-1.27M
--1.7M
-Change in prepaid assets
33.33%-420K
---630K
-Change in payables and accrued expense
-138.83%-1.25M
--3.22M
-Change in other working capital
145.27%402K
---888K
Cash from discontinued investing activities
Operating cash flow
-14.56%-44.16M
---38.54M
Investing cash flow
Cash flow from continuing investing activities
83.16%-678K
-4.03M
Net PPE purchase and sale
83.16%-678K
---4.03M
Cash from discontinued investing activities
Investing cash flow
83.16%-678K
---4.03M
Financing cash flow
Cash flow from continuing financing activities
-99.70%301K
100.16M
Net issuance payments of debt
-246.24%-322K
---93K
Net preferred stock issuance
--0
--100.2M
Proceeds from stock option exercised by employees
236.36%185K
--55K
Net other financing activities
--438K
----
Cash from discontinued financing activities
Financing cash flow
-99.70%301K
--100.16M
Net cash flow
Beginning cash position
213.71%84.54M
--26.95M
Current changes in cash
-177.33%-44.53M
--57.59M
End cash Position
-52.68%40M
--84.54M
Free cash flow
-5.32%-44.83M
---42.57M
Currency Unit
USD
USD
(FY)Dec 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.56%-44.16M-38.54M
Net income from continuing operations -11.54%-49.29M---44.19M
Depreciation and amortization 91.12%1.68M--878K
Other non cash items 7.69%1.82M--1.69M
Change In working capital -174.47%-1.27M--1.7M
-Change in prepaid assets 33.33%-420K---630K
-Change in payables and accrued expense -138.83%-1.25M--3.22M
-Change in other working capital 145.27%402K---888K
Cash from discontinued investing activities
Operating cash flow -14.56%-44.16M---38.54M
Investing cash flow
Cash flow from continuing investing activities 83.16%-678K-4.03M
Net PPE purchase and sale 83.16%-678K---4.03M
Cash from discontinued investing activities
Investing cash flow 83.16%-678K---4.03M
Financing cash flow
Cash flow from continuing financing activities -99.70%301K100.16M
Net issuance payments of debt -246.24%-322K---93K
Net preferred stock issuance --0--100.2M
Proceeds from stock option exercised by employees 236.36%185K--55K
Net other financing activities --438K----
Cash from discontinued financing activities
Financing cash flow -99.70%301K--100.16M
Net cash flow
Beginning cash position 213.71%84.54M--26.95M
Current changes in cash -177.33%-44.53M--57.59M
End cash Position -52.68%40M--84.54M
Free cash flow -5.32%-44.83M---42.57M
Currency Unit USDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday-1.44%